Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rhox4e
|
ENSMUSG00000071770.4 | reproductive homeobox 4E |
Rhox6
|
ENSMUSG00000006200.3 | reproductive homeobox 6 |
Vax2
|
ENSMUSG00000034777.1 | ventral anterior homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_83711396_83711569 | Vax2 | 218 | 0.732702 | 0.39 | 3.6e-03 | Click! |
chr6_83711028_83711367 | Vax2 | 67 | 0.741485 | 0.28 | 3.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_132427639_132427949 | 15.63 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chrX_166344291_166344543 | 13.55 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr11_112501711_112502406 | 13.39 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr3_40673604_40673797 | 13.11 |
Intu |
inturned planar cell polarity protein |
1079 |
0.49 |
chr3_78792451_78792970 | 12.65 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr8_47242449_47242654 | 12.08 |
Stox2 |
storkhead box 2 |
135 |
0.97 |
chr1_96346717_96347057 | 11.72 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr18_69608146_69608367 | 11.55 |
Tcf4 |
transcription factor 4 |
4188 |
0.32 |
chr5_20056465_20056826 | 11.36 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr12_4220043_4220458 | 11.35 |
Gm48210 |
predicted gene, 48210 |
1852 |
0.19 |
chrX_93301651_93301845 | 11.34 |
Arx |
aristaless related homeobox |
15238 |
0.23 |
chr13_99444397_99444879 | 11.10 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr16_63806441_63806811 | 10.88 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr9_23378360_23378672 | 10.59 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr8_90576969_90577137 | 10.47 |
Gm45639 |
predicted gene 45639 |
97905 |
0.07 |
chr6_112809545_112809826 | 10.25 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr9_9263661_9263812 | 10.21 |
Gm16833 |
predicted gene, 16833 |
3053 |
0.29 |
chr16_63747767_63748162 | 10.20 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr4_32940073_32940241 | 10.12 |
Ankrd6 |
ankyrin repeat domain 6 |
10669 |
0.15 |
chr7_36477217_36477414 | 9.95 |
Gm25247 |
predicted gene, 25247 |
46704 |
0.17 |
chr8_26677560_26678005 | 9.76 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chr5_9339805_9340127 | 9.69 |
Gm15733 |
predicted gene 15733 |
13793 |
0.19 |
chr12_58619814_58620024 | 9.57 |
Gm18873 |
predicted gene, 18873 |
143987 |
0.04 |
chr6_15397521_15397861 | 9.46 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr10_29143863_29144732 | 9.43 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr6_103514048_103514248 | 9.42 |
Chl1 |
cell adhesion molecule L1-like |
2818 |
0.24 |
chr1_81594178_81594459 | 9.41 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr15_95217343_95217494 | 9.37 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr17_11927079_11927230 | 9.28 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
81944 |
0.1 |
chr2_57916465_57916651 | 9.23 |
Gm33594 |
predicted gene, 33594 |
69459 |
0.11 |
chr13_84751597_84751791 | 9.19 |
Gm26913 |
predicted gene, 26913 |
60753 |
0.15 |
chr14_12338097_12338549 | 9.18 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr7_76789063_76789214 | 9.13 |
Gm45210 |
predicted gene 45210 |
89421 |
0.1 |
chr9_66933818_66934187 | 9.12 |
Rps27l |
ribosomal protein S27-like |
12084 |
0.15 |
chr1_157969609_157969781 | 9.10 |
Gm38256 |
predicted gene, 38256 |
29310 |
0.25 |
chr4_24429061_24429567 | 8.98 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr18_25548818_25548982 | 8.89 |
Celf4 |
CUGBP, Elav-like family member 4 |
47661 |
0.16 |
chr12_100242422_100242831 | 8.83 |
Gm40557 |
predicted gene, 40557 |
182 |
0.93 |
chr8_81770692_81770859 | 8.76 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
42 |
0.98 |
chr4_21665942_21666298 | 8.74 |
Gm11876 |
predicted gene 11876 |
4920 |
0.2 |
chrX_61393166_61393371 | 8.70 |
Gm14665 |
predicted gene 14665 |
4241 |
0.3 |
chr11_71414747_71415135 | 8.65 |
Gm16013 |
predicted gene 16013 |
21239 |
0.21 |
chr2_41093986_41094158 | 8.63 |
Gm13460 |
predicted gene 13460 |
95215 |
0.09 |
chr13_52457883_52458068 | 8.53 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr16_43502947_43503194 | 8.43 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
544 |
0.83 |
chr11_43270024_43270232 | 8.38 |
Gm12146 |
predicted gene 12146 |
10344 |
0.19 |
chrX_169838405_169838582 | 8.31 |
Mid1 |
midline 1 |
10334 |
0.25 |
chr11_43270302_43270711 | 8.19 |
Gm12146 |
predicted gene 12146 |
10722 |
0.19 |
chrX_103744635_103745105 | 8.17 |
Slc16a2 |
solute carrier family 16 (monocarboxylic acid transporters), member 2 |
10681 |
0.12 |
chr7_64884497_64884825 | 8.16 |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
11664 |
0.22 |
chr6_111293807_111293981 | 8.16 |
Grm7 |
glutamate receptor, metabotropic 7 |
201821 |
0.03 |
chr19_41164805_41164972 | 8.14 |
Tll2 |
tolloid-like 2 |
41886 |
0.16 |
chr2_142362908_142363300 | 8.07 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
186497 |
0.03 |
chr13_84783651_84783837 | 8.06 |
Gm26913 |
predicted gene, 26913 |
92803 |
0.09 |
chr5_4811967_4812118 | 8.00 |
Gm44483 |
predicted gene, 44483 |
9585 |
0.12 |
chr9_96726062_96726239 | 7.98 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
2886 |
0.23 |
chrX_60545622_60545821 | 7.97 |
Gm715 |
predicted gene 715 |
2298 |
0.23 |
chr13_8333561_8334203 | 7.91 |
Gm48260 |
predicted gene, 48260 |
34739 |
0.14 |
chr17_8368820_8369004 | 7.90 |
T2 |
brachyury 2 |
3484 |
0.15 |
chr1_3094927_3095127 | 7.90 |
Gm26206 |
predicted gene, 26206 |
6989 |
0.25 |
chr3_127652402_127652663 | 7.80 |
Neurog2 |
neurogenin 2 |
19397 |
0.11 |
chr2_152069243_152069466 | 7.78 |
AA387200 |
expressed sequence AA387200 |
7454 |
0.15 |
chr12_29789878_29790063 | 7.77 |
Myt1l |
myelin transcription factor 1-like |
50240 |
0.17 |
chr11_43217040_43217393 | 7.75 |
Gm12144 |
predicted gene 12144 |
15048 |
0.19 |
chr13_58964694_58965094 | 7.72 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr1_177411101_177411252 | 7.71 |
Gm26801 |
predicted gene, 26801 |
17908 |
0.17 |
chr6_54552680_54553127 | 7.71 |
Scrn1 |
secernin 1 |
1543 |
0.37 |
chr8_34326259_34326892 | 7.69 |
Gm4889 |
predicted gene 4889 |
1335 |
0.32 |
chr2_34129751_34129905 | 7.66 |
Gm38389 |
predicted gene, 38389 |
18384 |
0.2 |
chr8_47642536_47642697 | 7.62 |
Gm8623 |
predicted gene 8623 |
9852 |
0.12 |
chr6_127449629_127449900 | 7.55 |
Parp11 |
poly (ADP-ribose) polymerase family, member 11 |
501 |
0.78 |
chr8_103314608_103315058 | 7.52 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
32701 |
0.2 |
chr12_67272489_67272659 | 7.51 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
50025 |
0.15 |
chr8_98309156_98309407 | 7.48 |
Gm7192 |
predicted gene 7192 |
84618 |
0.1 |
chr19_29844038_29844382 | 7.47 |
Gm50380 |
predicted gene, 50380 |
31007 |
0.13 |
chr1_52079807_52079978 | 7.44 |
Gm28177 |
predicted gene 28177 |
2631 |
0.2 |
chr1_42703489_42704501 | 7.43 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr1_52470778_52471095 | 7.36 |
Nab1 |
Ngfi-A binding protein 1 |
3879 |
0.19 |
chr13_78324889_78325040 | 7.33 |
Gm3963 |
predicted gene 3963 |
37880 |
0.11 |
chr5_150894457_150894771 | 7.30 |
Gm43298 |
predicted gene 43298 |
11972 |
0.2 |
chr2_71517523_71517711 | 7.29 |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
2205 |
0.21 |
chr1_119189500_119189891 | 7.27 |
Gm8321 |
predicted gene 8321 |
32109 |
0.17 |
chr8_93731196_93731378 | 7.26 |
Gm30606 |
predicted gene, 30606 |
11312 |
0.17 |
chr9_41918609_41918944 | 7.22 |
Gm40513 |
predicted gene, 40513 |
28172 |
0.14 |
chr16_44579610_44579783 | 7.21 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
20799 |
0.19 |
chr3_79475048_79475264 | 7.18 |
Fnip2 |
folliculin interacting protein 2 |
8951 |
0.21 |
chr18_47246956_47247284 | 7.17 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
34075 |
0.17 |
chr5_140659637_140660247 | 7.15 |
Iqce |
IQ motif containing E |
6299 |
0.15 |
chr3_154817331_154817637 | 7.12 |
Gm18589 |
predicted gene, 18589 |
22123 |
0.2 |
chr8_49243134_49243285 | 7.11 |
Gm45832 |
predicted gene 45832 |
11240 |
0.28 |
chr19_59006658_59006882 | 7.11 |
Shtn1 |
shootin 1 |
31515 |
0.15 |
chr2_45356875_45357110 | 7.09 |
Gm13479 |
predicted gene 13479 |
273 |
0.94 |
chr7_73354299_73354479 | 7.07 |
Rgma |
repulsive guidance molecule family member A |
21120 |
0.13 |
chr19_29844410_29844642 | 7.06 |
Gm50380 |
predicted gene, 50380 |
30691 |
0.13 |
chr11_12742259_12742438 | 7.06 |
Gm22789 |
predicted gene, 22789 |
49535 |
0.17 |
chr8_7440241_7440417 | 7.04 |
Gm26427 |
predicted gene, 26427 |
12001 |
0.26 |
chr11_47069891_47070050 | 6.97 |
Gm12175 |
predicted gene 12175 |
195557 |
0.03 |
chrX_47124254_47124450 | 6.92 |
Gm14609 |
predicted gene 14609 |
256982 |
0.02 |
chr2_136745064_136745239 | 6.91 |
Gm14053 |
predicted gene 14053 |
536 |
0.81 |
chr16_77236959_77237505 | 6.91 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
913 |
0.66 |
chr19_14777449_14777621 | 6.91 |
Gm26026 |
predicted gene, 26026 |
59055 |
0.15 |
chr9_75085301_75085493 | 6.91 |
Gm9719 |
predicted gene 9719 |
13743 |
0.14 |
chr1_128860117_128860293 | 6.86 |
Gm23056 |
predicted gene, 23056 |
25814 |
0.23 |
chr18_27956389_27956743 | 6.86 |
Gm33674 |
predicted gene, 33674 |
146834 |
0.05 |
chr2_106078680_106078837 | 6.86 |
Gm29053 |
predicted gene 29053 |
38262 |
0.13 |
chr5_18137788_18137983 | 6.84 |
Gnat3 |
guanine nucleotide binding protein, alpha transducing 3 |
175336 |
0.03 |
chr9_118108526_118108688 | 6.84 |
Cmc1 |
COX assembly mitochondrial protein 1 |
41556 |
0.13 |
chr5_112041311_112041693 | 6.81 |
Gm42488 |
predicted gene 42488 |
97267 |
0.07 |
chr14_24550971_24551440 | 6.80 |
Rps24 |
ribosomal protein S24 |
60056 |
0.09 |
chr2_21270050_21270364 | 6.79 |
Gm13378 |
predicted gene 13378 |
26102 |
0.17 |
chr15_72657768_72657941 | 6.78 |
Gm28020 |
predicted gene, 28020 |
63533 |
0.11 |
chr19_56029412_56029721 | 6.77 |
D730002M21Rik |
RIKEN cDNA D730002M21 gene |
5530 |
0.24 |
chr10_70484969_70485278 | 6.77 |
Gm29783 |
predicted gene, 29783 |
20125 |
0.19 |
chr10_70458638_70458831 | 6.76 |
Fam13c |
family with sequence similarity 13, member C |
17808 |
0.19 |
chr5_4651240_4651409 | 6.75 |
Fzd1 |
frizzled class receptor 1 |
106711 |
0.06 |
chr3_34331071_34331263 | 6.73 |
Gm38505 |
predicted gene, 38505 |
20545 |
0.21 |
chr4_120170416_120170874 | 6.71 |
Edn2 |
endothelin 2 |
9439 |
0.24 |
chr7_36476904_36477159 | 6.71 |
Gm25247 |
predicted gene, 25247 |
46420 |
0.17 |
chr5_25652525_25652696 | 6.70 |
Gm43972 |
predicted gene, 43972 |
7199 |
0.15 |
chr18_69607136_69607287 | 6.69 |
Tcf4 |
transcription factor 4 |
5233 |
0.3 |
chr15_84531439_84531771 | 6.68 |
Rtl6 |
retrotransposon Gag like 6 |
26218 |
0.18 |
chrX_130820134_130820324 | 6.67 |
Gm26209 |
predicted gene, 26209 |
67549 |
0.13 |
chr13_78181182_78181614 | 6.66 |
Gm38604 |
predicted gene, 38604 |
1761 |
0.26 |
chr13_107407430_107407612 | 6.62 |
Apoo-ps |
apolipoprotein O, pseudogene |
7208 |
0.24 |
chr5_78622542_78622942 | 6.62 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chr4_54371542_54371700 | 6.59 |
Gm12469 |
predicted gene 12469 |
135745 |
0.05 |
chr1_4970686_4970886 | 6.59 |
Gm16041 |
predicted gene 16041 |
71 |
0.97 |
chr3_34667994_34668157 | 6.59 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2832 |
0.16 |
chr17_66869624_66870037 | 6.58 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr15_25754647_25755340 | 6.56 |
Myo10 |
myosin X |
2014 |
0.38 |
chr14_63586397_63586582 | 6.55 |
Xkr6 |
X-linked Kx blood group related 6 |
20014 |
0.15 |
chr12_96114939_96115347 | 6.51 |
1700019M22Rik |
RIKEN cDNA 1700019M22 gene |
68023 |
0.13 |
chr14_74360274_74360440 | 6.49 |
4933402J15Rik |
RIKEN cDNA 4933402J15 gene |
4830 |
0.27 |
chr3_119063263_119063539 | 6.48 |
Gm43410 |
predicted gene 43410 |
195157 |
0.03 |
chr1_193433813_193434005 | 6.46 |
Gm38022 |
predicted gene, 38022 |
41381 |
0.11 |
chr2_106084263_106084414 | 6.45 |
Gm29053 |
predicted gene 29053 |
43842 |
0.12 |
chr2_157340114_157340758 | 6.41 |
Ghrh |
growth hormone releasing hormone |
3010 |
0.22 |
chr2_45356622_45356819 | 6.40 |
Gm13479 |
predicted gene 13479 |
545 |
0.83 |
chr15_96178501_96178674 | 6.39 |
4833422M21Rik |
RIKEN cDNA 4833422M21 gene |
63202 |
0.11 |
chr14_62415985_62416195 | 6.38 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
38703 |
0.13 |
chr2_165745406_165745646 | 6.37 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
16298 |
0.2 |
chr12_56458764_56459233 | 6.36 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr4_22478892_22479069 | 6.35 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
9386 |
0.17 |
chr2_151631930_151632148 | 6.35 |
Snph |
syntaphilin |
432 |
0.78 |
chr2_122532290_122532446 | 6.35 |
Slc28a2b |
solute carrier family 28 member 2b |
46451 |
0.1 |
chr19_36000746_36000897 | 6.35 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
56519 |
0.12 |
chr5_25738330_25738858 | 6.34 |
Actr3b |
ARP3 actin-related protein 3B |
21403 |
0.13 |
chr10_33624726_33624916 | 6.33 |
Clvs2 |
clavesin 2 |
52 |
0.9 |
chr8_102698578_102698764 | 6.30 |
9430099M06Rik |
RIKEN cDNA 9430099M06 gene |
8119 |
0.2 |
chrX_157052043_157052237 | 6.29 |
Gm22666 |
predicted gene, 22666 |
1815 |
0.42 |
chr13_52562127_52562509 | 6.29 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr1_14294310_14294475 | 6.29 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
10178 |
0.25 |
chr6_32056516_32056667 | 6.28 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
1550 |
0.51 |
chr11_26806852_26807151 | 6.28 |
Gm12070 |
predicted gene 12070 |
20368 |
0.19 |
chr3_50634809_50634962 | 6.28 |
Gm37199 |
predicted gene, 37199 |
6474 |
0.19 |
chr17_63807674_63808197 | 6.27 |
Fer |
fer (fms/fps related) protein kinase |
55127 |
0.13 |
chr17_11664742_11664947 | 6.26 |
Gm10513 |
predicted gene 10513 |
67501 |
0.13 |
chrX_11494604_11494755 | 6.24 |
Gm14515 |
predicted gene 14515 |
106675 |
0.06 |
chr14_78132773_78132953 | 6.24 |
Fam216b |
family with sequence similarity 216, member B |
43856 |
0.12 |
chr1_41275340_41275552 | 6.24 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
94194 |
0.09 |
chr12_12684520_12684723 | 6.23 |
Gm27952 |
predicted gene, 27952 |
2003 |
0.29 |
chr12_92589457_92589626 | 6.23 |
Gm18500 |
predicted gene, 18500 |
115580 |
0.07 |
chr5_15985726_15985932 | 6.19 |
Gm43000 |
predicted gene 43000 |
12010 |
0.19 |
chr6_22202002_22202201 | 6.19 |
Gm42573 |
predicted gene 42573 |
43833 |
0.16 |
chr12_51000444_51000673 | 6.19 |
Gm40421 |
predicted gene, 40421 |
4315 |
0.24 |
chr13_83750227_83750397 | 6.18 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr19_21781727_21782179 | 6.17 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
3565 |
0.26 |
chr13_94376190_94376445 | 6.17 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
17357 |
0.17 |
chr19_21494190_21494506 | 6.17 |
Gda |
guanine deaminase |
20903 |
0.22 |
chr2_101979368_101979730 | 6.16 |
Gm13919 |
predicted gene 13919 |
60080 |
0.11 |
chr10_72099529_72099696 | 6.15 |
Gm34609 |
predicted gene, 34609 |
72630 |
0.1 |
chr5_99062665_99062987 | 6.15 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
25475 |
0.2 |
chr3_144223863_144224044 | 6.13 |
Lmo4 |
LIM domain only 4 |
18733 |
0.18 |
chr3_98990771_98991097 | 6.11 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr5_97289764_97289960 | 6.10 |
Gm5560 |
predicted pseudogene 5560 |
25034 |
0.17 |
chr4_118256300_118256531 | 6.09 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
19970 |
0.16 |
chr18_78455374_78455574 | 6.09 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21404 |
0.24 |
chr4_114678225_114678705 | 6.08 |
Gm12829 |
predicted gene 12829 |
2339 |
0.32 |
chr16_67175484_67175665 | 6.07 |
Gm49640 |
predicted gene, 49640 |
62776 |
0.16 |
chr2_170731351_170731715 | 6.06 |
Dok5 |
docking protein 5 |
274 |
0.94 |
chr10_87666126_87666297 | 6.06 |
Gm48195 |
predicted gene, 48195 |
22367 |
0.23 |
chr14_35112923_35113111 | 6.05 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr4_142292438_142292653 | 6.04 |
Kazn |
kazrin, periplakin interacting protein |
53144 |
0.13 |
chr5_10417959_10418110 | 6.04 |
Gm17091 |
predicted gene 17091 |
119251 |
0.05 |
chr3_76654290_76654629 | 6.03 |
Fstl5 |
follistatin-like 5 |
60909 |
0.15 |
chr10_52742737_52743261 | 6.03 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr16_62686085_62686411 | 6.00 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr18_22338923_22339083 | 5.97 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
5243 |
0.35 |
chr4_20401022_20401283 | 5.97 |
Gm11873 |
predicted gene 11873 |
10056 |
0.28 |
chr1_6752243_6752413 | 5.97 |
St18 |
suppression of tumorigenicity 18 |
14753 |
0.25 |
chr16_41786838_41787032 | 5.97 |
Lsamp |
limbic system-associated membrane protein |
253516 |
0.02 |
chr7_89677956_89678122 | 5.96 |
A230065N10Rik |
RIKEN cDNA A230065N10 gene |
44915 |
0.12 |
chr3_107066739_107066904 | 5.96 |
A930002I21Rik |
RIKEN cDNA A930002I21 gene |
24059 |
0.12 |
chr14_59969965_59970150 | 5.95 |
Gm9013 |
predicted gene 9013 |
70434 |
0.11 |
chr15_37787189_37787357 | 5.94 |
Ncald |
neurocalcin delta |
4727 |
0.2 |
chr4_13599724_13600127 | 5.92 |
Gm11825 |
predicted gene 11825 |
6109 |
0.25 |
chr18_9027171_9027529 | 5.88 |
Gm7523 |
predicted gene 7523 |
59606 |
0.13 |
chr14_31934365_31934741 | 5.88 |
D830044D21Rik |
RIKEN cDNA D830044D21 gene |
28025 |
0.16 |
chr2_118203496_118203665 | 5.88 |
Gm22800 |
predicted gene, 22800 |
45202 |
0.1 |
chr3_50634552_50634703 | 5.87 |
Gm37199 |
predicted gene, 37199 |
6216 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 15.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.6 | 7.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.2 | 6.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.7 | 6.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.7 | 8.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.6 | 4.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.5 | 4.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.4 | 10.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 2.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 5.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.3 | 8.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.3 | 11.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 3.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.3 | 9.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 6.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.2 | 5.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 4.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.1 | 12.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.1 | 3.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 3.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 2.9 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 2.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.9 | 1.7 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.8 | 4.1 | GO:0021764 | amygdala development(GO:0021764) |
0.8 | 4.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 6.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.8 | 2.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.8 | 3.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 3.0 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.7 | 2.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 1.5 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.7 | 2.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.7 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 2.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 2.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 2.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.6 | 5.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 1.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 5.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 0.6 | GO:0031223 | auditory behavior(GO:0031223) |
0.6 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.6 | 1.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 1.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 1.8 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.6 | 6.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 6.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 1.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 1.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.5 | 0.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.5 | 0.5 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.5 | 1.6 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 2.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 3.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 1.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.5 | 2.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 2.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.5 | 0.5 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.5 | 2.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 1.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 7.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 1.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 1.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 1.0 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.5 | 2.9 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.5 | 0.9 | GO:0048880 | sensory system development(GO:0048880) |
0.5 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 2.2 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.8 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.4 | 1.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 2.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 2.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 6.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 2.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 1.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 2.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.4 | 0.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 1.2 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.4 | 3.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 6.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 1.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 1.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 1.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 0.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.4 | 1.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 1.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 1.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 1.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.4 | 0.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 1.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.4 | 1.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 0.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 2.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.7 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 1.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.3 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 2.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 6.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.3 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 3.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.3 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.3 | 1.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 1.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.3 | 0.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.3 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 0.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 1.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 1.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.8 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 1.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 0.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 3.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 0.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 2.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.7 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.5 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.4 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.4 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 10.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 1.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 0.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 14.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 1.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.7 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 1.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.3 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.8 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 1.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 0.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.8 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.3 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0035482 | gastric motility(GO:0035482) |
0.1 | 0.3 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.1 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.7 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 1.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.4 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.3 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 1.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.6 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 1.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 2.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 1.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.4 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.5 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.1 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.1 | 0.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.1 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 2.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 1.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.9 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.2 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.1 | 1.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 2.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0072243 | metanephric nephron epithelium development(GO:0072243) |
0.0 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.7 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.5 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0043476 | pigment accumulation(GO:0043476) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.3 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.0 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 1.4 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.0 | 0.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.0 | 0.5 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.4 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0072534 | perineuronal net(GO:0072534) |
2.1 | 6.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 7.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 7.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 3.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 4.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 2.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 10.1 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 0.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 11.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 0.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 4.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 4.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 1.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 3.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 6.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 2.2 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 1.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 4.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 18.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 3.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 4.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 3.0 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 6.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.8 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 7.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 2.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 4.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 8.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 6.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 3.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 4.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 2.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.5 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 4.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 3.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.4 | 9.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.2 | 6.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.2 | 6.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 6.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 2.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 4.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 3.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.0 | 3.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 9.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 2.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 3.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 2.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 2.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 1.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 3.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 5.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 2.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 1.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 0.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 9.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 3.5 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 7.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 2.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 5.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 2.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 0.7 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 6.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 8.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 6.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 3.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 2.0 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 5.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 1.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 2.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 3.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 2.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 1.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 4.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 3.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 2.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 3.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 3.2 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 1.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 2.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 1.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 1.0 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 5.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 2.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0034950 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 22.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 4.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 5.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 4.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 14.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 3.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 5.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 4.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 7.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 3.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 5.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 6.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 8.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 1.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 4.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 2.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |